Cristal Therapeutics is a pharmaceutical company developing targeted nanomedicines against cancer and other diseases, by using its patented CriPec® platform technology.

Both new and existing drugs can be combined with CriPec®, to optimize the therapeutic performance of drugs and thereby improve patient care.

Company: Cristal Therapeutics
Fund: I
Status: active
Team member: Michel Briejer
Technology: Therapeutics
Website: cristaltherapeutics.com